Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR
- 1 June 1998
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 124 (3), 479-484
- https://doi.org/10.1038/sj.bjp.0701859
Abstract
1. The immediate effect of administration of 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') on rectal temperature and the effect of putative neuroprotective agents on this change has been examined in rats. The influence of the temperature changes on the long term MDMA-induced neurodegeneration of cerebral 5-hydroxytryptamine (5-HT) nerve terminals was also examined. 2. The novel low affinity N-methyl-D-aspartate (NMDA) receptor channel blocker AR-R15896AR (20 mg kg(-1), i.p.) given 5 min before and 55 min after MDMA (15 mg kg(-1), i.p.) did not prevent the MDMA-induced hyperthermia and did not alter either the MDMA-induced neurodegenerative loss of 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) in cortex, striatum and hippocampus or loss of [3H]-paroxetine binding in cortex 7 days later. 3. The neuroprotective agent clomethiazole (50 mg kg(-1), i.p.) given 5 min before and 55 min after MDMA (15 mg kg(-1)) abolished the MDMA-induced hyperthermic response and markedly attenuated the loss of 5-HT, 5-HIAA and [3H]-paroxetine binding in the brain regions examined 7 days later. 4. When rats treated with MDMA plus clomethiazole were kept at high ambient temperature for 5 h post-MDMA, thereby keeping their body temperature elevated to near that seen in rats given MDMA alone, the MDMA-induced loss of 5-HT, 5-HIAA and [3H]-paroxetine was still attenuated. However, the protection (39%) afforded by the clomethiazole administration was less than seen in rats kept at normal ambient temperature (75%). 5. These data support the proposals of others that NMDA receptor antagonists are neuroprotective against MDMA-induced degeneration only if they induce hypothermia and further suggest that increased glutamate activity may not be involved in the neurotoxic action of MDMA. 6. These data further demonstrate that a proportion of the neuroprotective action of clomethiazole is due to an effect on body temperature but that, in addition, the compound protects against MDMA-induced damage by an unrelated mechanism.Keywords
This publication has 28 references indexed in Scilit:
- Low‐Affinity NMDA Receptor AntagonistsAnnals of the New York Academy of Sciences, 1997
- The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramineNeuropharmacology, 1996
- Neuroprotection after Several Days of Mild, Drug-Induced HypothermiaJournal of Cerebral Blood Flow & Metabolism, 1996
- ARL-15896, a NovelN-Methyl-D-aspartate Receptor Ion Channel Antagonist: Neuroprotection against Mitochondrial Metabolic Toxicity and Regional PharmacologyExperimental Neurology, 1996
- Brain Temperature Alters Hydroxyl Radical Production during Cerebral Ischemia/Reperfusion in RatsJournal of Cerebral Blood Flow & Metabolism, 1996
- Detection of Free Radical Activity During Transient Global Ischemia and Recirculation: Effects of Intraischemic Brain Temperature ModulationJournal of Neurochemistry, 1995
- The neuroprotective actions of chlormethiazoleProgress in Neurobiology, 1994
- Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to ratsNeuropharmacology, 1994
- Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the ratPharmacology Biochemistry and Behavior, 1991
- Small Differences in Intraischemic Brain Temperature Critically Determine the Extent of Ischemic Neuronal InjuryJournal of Cerebral Blood Flow & Metabolism, 1987